Board on Health Sciences Policy & Institute of Medicine 
Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research 
Workshop Summary

Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.